Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
HeartWare International is recalling its HVAD implantable heart pump over issues with worn alignment guides and connection pins that could lead to the pump stopping, according to the FDA.
The FDA labeled it a Class I recall, the most serious type of recall issued by the federal watch dog, indicating that “there is a reasonable probability that use of these products will cause serious adverse health consequences or death.” Read more
Hill-Rom Holdings said that it agreed to pay more than $2 billion to acquire point-of-care diagnostic device maker Welch Allyn in a cash-and-stock deal that will leave privately owned Welch Allyn’s shareholders owning a 13% stake in Hill-Rom.
The deal, expectd to close by the end of September, calls for Chicago-based Hill-Rom to pay $1.625 billion and 8.1 million HRC shares for Welch Allyn, which is based in Skaneateles Falls, N.Y. Read more
The Republican-led U.S. House of Representatives is moving ahead with a vote on repealing the medical device tax, despite a threat from the White House that President Barack Obama will veto the bill if it makes it to his desk.
The House Rules committee advanced H.R. 160, “Protect Medical Innovation Act of 2015,” to the House floor for a vote, a day after the White House’s Office of Management & Budget said the bill is nothing more than “a large tax break to profitable corporations. Read more